On September 6, the Fourth REAL Technology Conference hosted by Jiemian News was held in Shanghai, with the theme "Large Model Implementation: Reshaping Real-world Scenarios." The conference delved into the current state and future trends of AI large models, as well as how large models will spark innovation in industries such as healthcare, video, humanoid robotics, and finance. During the event, Jiemian News announced the "REAL 100 Innovators," "REAL 100 Innovative Institutions," and "REAL Company" lists. From hundreds of shortlisted companies, Jiemian News selected those that best represent cutting-edge industry trends—companies, investment institutions, and product projects that have not only achieved remarkable success in technological innovation but also played a significant role in driving industrial progress and societal development.DP Technology Honored with "2024 REAL Innovator of the Year" Award for Outstanding Achievements in Drug Computing and Design.
The "REAL 100 Innovators" list covers seven popular tracks: AI large models, AI + applications, new healthcare, intelligent driving and low-altitude economy, internet and lifestyle, new energy and new materials, hard technology and advanced manufacturing, showcasing the diverse innovative forces of the year. The list is comprehensively selected by examining the valuation scale, industry position, innovation ability, business potential, growth speed, and social evaluation of the registered companies. Their commonality lies in the relentless pursuit of innovation and the bold exploration of unknown fields.DP Technology's advanced drug computational design platform Hermite®, built on AI for Science, serves as a next-generation drug computational design platform based on artificial intelligence, physical modeling, and high-performance computing, providing a one-stop computational solution for preclinical drug discovery. The platform covers core functional modules such as protein structure prediction and optimization, protein property prediction, drug-target binding mode prediction, hit compound screening, lead compound optimization, drug molecule property prediction and recommendation, while offering a new generation of web-based interactive experience for drug molecules, bringing cross-terminal intelligent collaboration to drug discovery scientists. The platform features diverse molecular display, selection, and editing functions, especially allowing scientists to view protein and drug molecular structures in real time when using computational functions and analyzing results, facilitating decision-making and sharing based on the overall structure. Additionally, the platform supports project-level data confidentiality management, flexibly adapting to collaborative needs across different R&D pipelines, and can be flexibly deployed in local or cloud environments, comprehensively supporting the research work of drug discovery scientists.RiDYMO®: DP Technology's Undruggable Target R&D Platform Offers New Possibilities for Structure-Based Drug Design in the Form of an End-to-End Computational Toolkit. Integrating DP Technology's Self-Developed Uni-Fold Protein Folding Large Model and RiD (Reinforced Dynamics) Enhanced Sampling Algorithm, It Enables Efficient Structural Analysis and Refinement of Complex Protein Systems While Accurately Capturing Protein Dynamic Characteristics, Providing Novel Insights for Drug Design Across a Range of Scenarios.Notably, while DP Technology has achieved significant research and application outcomes across multiple fields, including biomedicine and new battery materials, it has also developed and refined a scientific large model system based on AI for Science — DP Universe®. This system transitions research methods in various disciplines from the "trial-and-error/experimental or computational" era into the "pre-trained model era." We are committed to providing five intelligent R&D solutions tailored to the needs of the field: literature review for domain development, experimental simulation design, characterization testing, process optimization, and analytical optimization. By adopting an R&D paradigm that integrates "software and hardware, experiments with computational simulations," we aim to build a complete closed-loop system spanning theoretical research, laboratory testing, and industrial applications, offering comprehensive technical support and innovative solutions to the industry.On the same day, as a representative of the biopharmaceutical track, DP Technology participated in the thematic sharing session on "The Fiery Layout and Pragmatic Thinking of AI + Healthcare." DP Technology engaged in an insightful discussion with representatives from Frees Fund, Easy Group, DeepWisdom Medical, and Lightsource Capital. From the perspectives of technical managers, venture capital institutions, and industry practitioners, they shared their views on the prospects, opportunities, and challenges in the AI + healthcare field.The REAL Technology Conference is an annual summit held by The Interface News in the technology industry, which has been successfully held for three consecutive years. This year's conference is set within the 2024 Inclusion·Bund Summit, aiming to spread the power of technological innovation to a wider audience and more groups. As a representative in the new healthcare track, DP Technology has consistently been a pioneer and practitioner of the "AI for Science" research paradigm. It is committed to building micro-scale industrial infrastructure led by AI for Science, focusing on creating platform tools and full-stack solutions that empower more fields through AI for Science, while actively developing an open ecosystem based on AI for Science.In 2024, we continue to witness how large models are reshaping real-world scenarios, with technological innovation delivering outstanding results. This not only injects new vitality into artificial intelligence companies represented by DP Technology but also propels industrial development on a global scale. We are at a critical juncture where innovation leads the development of the times. DP Technology looks forward to collaborating with more innovators to build an "innovation-to-implementation" chain and open ecosystem for AI for Science, empowering "industries across the board" and continuously driving industrial exploration towards a smarter, more efficient, and sustainable future.
DP Technology is a leader and practitioner of the "AI for Science" research paradigm. AI for Science involves using AI to learn a series of scientific principles and knowledge, and further addressing key issues in scientific research and industrial R&D.DP Technology, relying on its deep cultivation in interdisciplinary fields, has built "Deep Potential · Cosmic Insight®"AI for Science Large Model System ushers research methodologies across numerous disciplines from the 'experimental trial-and-error/computer' era into the 'pre-trained model era,' with 'micro-scale industrial design and simulation' as the entry point, creating...Bohrium®Bohr®Research Space Station, Hermite® Drug Computational Design Platform, RiDYMO® Difficult-to-Drug Target R&D Platform and Piloteye®Research and industrial R&D infrastructure such as battery design automation platforms have formed the "innovation-to-application" chain and an open ecosystem for AI for Science, empowering "thousands of industries." This creates a new generation of industrial design and simulation systems for the most fundamental areas of human economic development: biomedicine, energy, materials, and information science and engineering research.DP Technology is a national high-tech enterprise and a national specialized and new "little giant" enterprise, with research and development centers located in cities such as Beijing, Shanghai, and Shenzhen.The scientific research and technology team is led by an academician of the Chinese Academy of Sciences, bringing together over a hundred outstanding young scientists and engineers from various fields such as mathematics, physics, chemistry, biology, materials, and computer science. Among the company's members, those with doctoral degrees or postdoctoral experience account for more than 35%.Core members have won the 2020 Gordon Bell Prize, the highest award in the field of global high-performance computing, and their related work was selected as one of China's top ten scientific and technological advances in 2020 and one of the ten major technological breakthroughs in the global AI field.
